Home > Healthcare > Drug Device Combination > Uropathy Treatment Market
Uropathy Treatment Market Size
- Report ID: GMI9581
- Published Date: May 2024
- Report Format: PDF
Uropathy Treatment Market Size
Uropathy Treatment Market size was valued at USD 4.7 billion in 2023 and is estimated to grow at 4.1% CAGR from 2024 and 2032. The market is expected to experience considerable growth due to the increasing incidence of urinary tract disorders such as urinary tract infections (UTIs), kidney stones, benign prostatic hyperplasia (BPH), and other urological conditions.
According to the National Institutes of Health (NIH), symptoms of urinary retention occur up to 1% to 2% of men with BPH per year. This has contributed to the growing demand for uropathy treatment, as urinary retention is a significant complication of BPH. Thus, widespread adoption uropathy treatment will spur the market growth.
Uropathy, also known as obstructive uropathy, a treatment refers to the comprehensive management and care aimed at treating and alleviating disorders affecting the urinary tract obstructive disorder. This includes conditions such as UTIs, kidney stones, BPH, urethral strictures, urinary incontinence, and other urological disorders.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Uropathy Treatment Market Size in 2023: | USD 4.7 Billion |
| Forecast Period: | 2024 – 2032 |
| Forecast Period 2024 – 2032 CAGR: | 4.1% |
| 2024 – 2032 Value Projection: | USD 6.7 Billion |
| Historical Data for: | 2021 – 2023 |
| No. of Pages: | 150 |
| Tables, Charts & Figures: | 272 |
| Segments covered: | Treatment Type, Age Group, End-user, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Uropathy Treatment Market Scope
